Internal Medicine, Pulmonary Disease · Davenport, IA
NPI
1770819591
Since 2009
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1801 E 54th St, Ste 100
Davenport, IA, 52807
Phone (536) 323-1229
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
2,013 services
Medicare patients, 2024
676
Average age 75
Drug cost, 2024
$1.7M
4,781 prescriptions
Company payments, 2025
$3,620
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anand Kommuri was code 99214 (office e&m - established), 516 times for 311 patients. In total Anand Kommuri billed 2,013 services in 57 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 516 | 311 | $89.59 | $46K |
| 99232 Hospital E&M - Subsequent | Facility | 273 | 123 | $57.80 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 132 | 64 | $87.05 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 110 | 107 | $12.28 | $1,351 |
| 94729 Pulmonary Function Testing | Facility | 103 | 103 | $6.10 | $628 |
| 94726 Pulmonary Function Testing | Facility | 97 | 97 | $8.22 | $797 |
| 99213 Office E&M - Established | Office | 82 | 69 | $60.91 | $4,995 |
| 99204 Office E&M - New | Office | 64 | 64 | $119.54 | $7,651 |
| 94060 Pulmonary Function Testing | Facility | 57 | 57 | $6.91 | $394 |
| 94010 Pulmonary Function Testing | Office | 55 | 54 | $18.71 | $1,029 |
| 94010 Pulmonary Function Testing | Facility | 55 | 52 | $5.80 | $319 |
| 99291 Critical Care E&M | Facility | 53 | 25 | $156.16 | $8,277 |
| 99223 Hospital E&M - Initial | Facility | 51 | 49 | $121.54 | $6,199 |
| 99406 Behavioral Health Services | Office | 50 | 36 | $13.55 | $678 |
| 99222 Hospital E&M - Initial | Facility | 30 | 29 | $96.32 | $2,890 |
By year: 2022 $133K for 2,237 services; 2023 $140K for 2,159 services; 2024 $125K for 2,013 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88738 General Laboratory | 30 | 30 | $4.92 | $148 |
Medicare prescription drug claims, 2024
In 2024, the drug Anand Kommuri prescribed most often to Medicare patients was Montelukast Sodium, with 843 prescriptions and refills. In total Anand Kommuri wrote 4,781 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 843 | 1,781 | 230 | $6,527 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 572 | 635 | 194 | $14K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 337 | 405 | 72 | $256K |
| Azithromycin Generic | 318 | 396 | 68 | $2,761 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 211 | 242 | 43 | $156K |
| Roflumilast Generic | 182 | 229 | 41 | $14K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 178 | 199 | 34 | $91K |
| Breo Ellipta Fluticasone/Vilanterol | 152 | 180 | 34 | $70K |
| Prednisone Generic | 131 | 145 | 68 | $457 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 130 | 140 | 28 | $64K |
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 117 | 137 | 24 | $58K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 112 | 124 | 28 | $11K |
| Symbicort Budesonide/Formoterol Fumarate | 108 | 139 | 30 | $30K |
| Spiriva Respimat Tiotropium Bromide | 106 | 118 | 24 | $61K |
| Fluticasone Propionate Generic | 83 | 134 | 36 | $1,075 |
Brand drugs: 2,208 claims; generic drugs: 2,573 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anand Kommuri $3,620 ($3,620 in general payments such as food, travel and fees) from 12 companies. The largest payer was Intuitive Surgical, Inc. with $3,170.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 5 | $3,170 |
| Verona Pharma, Inc. VRNA | 3 | $105 |
| United Therapeutics Corporation UTHR | 2 | $61.44 |
| Pfizer Inc. PFE | 2 | $42.16 |
| Insmed, Inc. INSM | 2 | $40.68 |
| ERBE USA Inc | 1 | $38.57 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $35.16 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $34.17 |
| Mallinckrodt Hospital Products Inc. | 1 | $30.53 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $27.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.